| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2023 | Altshuler David48 | EVP, Global Research And CSO | Sell | 4,798 | $298.90 | $1,434,126.48 | -2.1% | +16.5% | +39.1% | |
| Feb 13, 2023 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 113 | $300.39 | $33,944.07 | -0.2% | +16.5% | +39.1% | |
| Feb 6, 2023 | Altshuler David48 | EVP, Global Research And CSO | Sale+OE | 1,304 | $306.00 | $399,021.78 | -0.3% | +12.9% | +36.5% | |
| Jan 31, 2023 | Sachs Bruce I51 | Director | Sale+OE | 1,200 | $325.01 | $390,012.00 | -2.8% | +6.8% | +34.1% | |
| Jan 31, 2023 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 106 | $325.00 | $34,450.00 | -0.3% | +6.8% | +34.1% | |
| Jan 30, 2023 | Carney Lloyd47 | Director | Sell | 2,700 | $320.52 | $865,406.24 | -16.1% | +7.8% | +39.4% | |
| Jan 27, 2023 | Lee Yuchun | Director | Sale+OE | 1,429 | $322.03 | $460,176.89 | -17.5% | +5.6% | +33.8% | |
| Jan 26, 2023 | Lee Yuchun | Director | Sale+OE | 8,000 | $316.15 | $2,529,174.49 | -20.9% | +0.7% | +34.0% | |
| Jan 25, 2023 | Kewalramani Reshma55 | CEO &President | Sell | 10,000 | $315.05 | $3,150,500.00 | -10.0% | +5.3% | +36.4% | |
| Jan 24, 2023 | Lee Yuchun | Director | Sale+OE | 6,129 | $312.46 | $1,915,043.81 | -46.3% | +6.1% | +36.4% |